Myelodysplastic syndromes can be treated with iron expectorants, pro-hematopoietic drugs, biological response modifiers, chemotherapeutic drugs, etc. Commonly used drugs include Deferasirox, methyltestosterone, thalidomide, etc. Patients with high prokaryotic cells can use chemotherapeutic drugs, such as cytarabine, etc., as per the doctor’s instructions. 1. Iron-removing drugs: Iron-removing drugs are mainly used for the treatment of iron overload caused by long-term blood transfusion, and commonly used oral iron removing drugs include Deferasirox and so on. 2. Pro-hematopoietic drugs: pro-hematopoietic drugs can improve the hematopoietic function of patients and promote the recovery of the disease, commonly used oral drugs are androgenic drugs such as methyltestosterone. 3. Biological response modifiers: patients can use thalidomide to improve hematopoietic function as prescribed by doctors. 4. Chemotherapeutic drugs: If the patient’s physical ability is relatively good, but the progenitor cells are on the high side, the patient needs to follow the doctor’s instructions to use Zoerythromycin, cytarabine and other drugs to carry out chemotherapy. Myelodysplastic syndromes are recommended to consult the doctor in time and take relevant drugs under the guidance of the doctor for treatment.